Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
RecruitingObservational studyHealthy volunteers welcome
Community-viable Screening for Autism Spectrum Disorder (ASD) in 9-month-old Infants Using Quantitative Eye-tracking Assays of Social Visual Engagement
Who can join
8 Months – 10 Months · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Infants between the chronological ages of 8-10 months * Infants must be generally healthy with no acute illnesses likely to prevent successful or valid data collection (e.g., current vomiting, high fever, conjunctivitis affecting vision) * Participants' parents/caregivers must be able to understand and voluntarily provide written informed consent. Exclusion Criteria: \- Children will be excluded if they have signs of acute illness likely to prevent successful or valid data collection (e.g., conjunctivitis affecting vision, current vomiting, or high fever).
About the study
The goal of this project is to measure the clinical utility of an objective and quantitative eye-tracking assay collected on a standalone, mobile investigational device to accurately screen 9-month-old infants for autism spectrum disorder and other actionable delays.
What is being tested
- EarliPoint Investigational Device (diagnostic test)
Sponsor: Emory University · Participants: 2,120 · Started: Feb 2, 2023
Contact the study team
- FirstFocus Study · Phone: 404-785-4529
Official record on ClinicalTrials.gov — NCT05916430
Locations in the U.S.
| Georgia | Children's Healthcare of Atlanta, Atlanta Emory University, Atlanta |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.